|
ZMYM6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-16 |
| Normal-vs-Stage2 |
1.08880016114199E-10 |
| Normal-vs-Stage3 |
5.10702591327572E-15 |
| Normal-vs-Stage4 |
3.84137166520304E-14 |
| Stage1-vs-Stage2 |
3.238000E-01 |
| Stage1-vs-Stage3 |
6.020200E-02 |
| Stage1-vs-Stage4 |
1.639680E-02 |
| Stage2-vs-Stage3 |
7.047000E-01 |
| Stage2-vs-Stage4 |
2.541600E-01 |
| Stage3-vs-Stage4 |
4.059800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
9.45859999990084E-07 |
| Normal-vs-Asian |
6.67830013512116E-10 |
| Caucasian-vs-AfricanAmerican |
9.164000E-01 |
| Caucasian-vs-Asian |
7.818800E-01 |
| AfricanAmerican-vs-Asian |
7.946400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.99680288865056E-15 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
9.170000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6269208202857E-12 |
| Normal-vs-Age(41-60Yrs) |
7.7715611723761E-16 |
| Normal-vs-Age(61-80Yrs) |
1.65989444411707E-12 |
| Normal-vs-Age(81-100Yrs) |
1.046930E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.217400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.271220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.349200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.636400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.361800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.494400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.424110E-02 |
| Classical-VS-Follicular |
1.882380E-01 |
| Classical-VS-Other |
7.445400E-01 |
| Classical-VS-Normal |
2.1622004187094E-10 |
| Tall-VS-Follicular |
1.322840E-01 |
| Tall-VS-Other |
3.390800E-01 |
| Tall-VS-Normal |
5.03264097062583E-12 |
| Follicular-VS-Other |
9.140800E-01 |
| Follicular-VS-Normal |
1.33989486172936E-11 |
| Other-VS-Normal |
2.999800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
7.38520022913747E-10 |
| N0-vs-N1 |
7.979200E-01 |
|
|
